retatrutide trial weight loss results The next big shift in obesity care may not be surgery — it may be a weekly shot. Retatrutide, an investigational triple-action medicine, showed 28.3% average body-weight over 80 weeks in Retatrutide vs Tirzepatide: Which Peptide

What happens after I stop taking GLP-1 medication

This can lead to ineffective benefits in both weight and blood sugar control

One of the major benefits they have for people who take the drug for obesity is that they diminish the craving for food

Pregnant or breastfeeding women are typically advised against use due to insufficient research

Will I be able to communicate with a provider

According to FDA guidance, compounded medications are prepared by licensed pharmacies based on individual prescriptions using FDA-approved active ingredients, but the finished compounded products themselves are not FDA-approved and have not undergone the same regulatory review for safety, effectiveness, and quality that approved drugs receive